Cash
Portfolio
TrendingMidtermsElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive243AccountSocial
MARKETSINVESTLIVE243
Product
Kalshi ProInvestMarketsIncentive programInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQFee scheduleTrading hoursRegulatoryTrust Center

© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
Series Image
  1. Medicine

When will the FDA reclassify BPC-157 to Category 1?



Chance

Before November
<1%

Before November

<1%

Before 2027
24%
▲ 1

Before 2027

24%
▲ 1

Before September
No

Before September

No

3 more

When will the FDA reclassify BPC-157 to Category 1?

Before November

Odds
1% chance
Max payout
Nov 1, 2026
$0
$141,836 vol
More Science and Technology Markets

Trending Science and Technology markets

Best AI at the end of 2026?Will the U.S. confirm that aliens exist?Top Chinese AI Company week of October 26thAnthropic market share this weekOpenAI market share this weekOpenRouter token usage in Oct 26–Nov 1Tesla Optimus released this year?Where will Waymo operate this year?

Science and Technology hub

All Science and Technology markets